BAY 86-9766

BAY-86-9766 · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY 86-9766, covering 2013-09-06 to 2013-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer. [Phase 2]